Gene table: Epilepsy (update)

European Journal of Paediatric Neurology

Volumn 4, Issue 2, 2000, Pages 87-90

  Elmslie, Frances ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; CYSTATIN B; GENE PRODUCT; NEUROFIBROMIN; PALMITOYL PROTEIN THIOESTERASE; POTASSIUM CHANNEL; PROTEIN; SODIUM CHANNEL; TUBERIN; UBIQUITIN PROTEIN LIGASE;

EPILEPSY; GENE; GENE LOCATION; HUMAN; INHERITANCE; PRIORITY JOURNAL; REVIEW;

EID: 0034163763     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejpn.2000.0269     Document Type: Review

References (60)

1. Leppert M, Anderson VE, Quattlebaum T et al. Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 1989; 337: 647-648.
2. Biervert C, Schroeder BC, Kubisch C et al. A potassium channel mutation in neonatal human epilepsy. Science 1998; 279: 406-409.
3. Singh NA, Charlier C, Stauffer D et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nature Genet 1998; 18: 25-29.
4. Lewis TB, Leach RJ, Ward K et al. Genetic heterogeneity in benign familial neonatal convulsions: Identification of a new locus on chromosome 8q. Am J Hum Genet 1993; 53: 670-675.
5. Charlier C, Singh NA, Ryan SG et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nature Genet 1998; 18: 53-55.
6. Guipponi M, Rivier F, Vigevano F et al. Linkage mapping of benign infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet 1997; 6: 473-477.
7. Gennaro E, Malacarne M, Carbone I et al. No evidence for a major locus for benign familial infantile convulsions on chromosome 19q12-q13.1. Epilepsia 1999; 40: 1799-1803.
8. Phillips HA, Scheffer IE, Berkovic SF et al. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q13.2. Nature Genet 1995; 10: 117-118.
9. Steinlein OK, Mulley JC, Propping P et al. A missense mutation in the neuronal receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Genet 1995; 11: 201-203.
10. Steinlein OK, Magnusson A, Stoodt J et al. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet 1997; 6: 943-947.
11. Hirose S, Iwata H, Akiyoshi H et al. A novel mutation in CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology 1999; 53:1749-1753.
12. Phillips HA, Scheffer IE, Crossland KM et al. Autosomal dominant nocturnal frontal-lobe epilepsy: Genetic heterogeneity and evidence for a second locus at 15q24. Am J Hum Genet 1998; 63: 1108-1116.
13. Ottman R, Risch N, Hauser WA et al. Localization of a gene for partial epilepsy to chromosome 10q. Nature Genet 1995; 10: 56-60.
14. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus: A genetic disorder with heterogeneous clinical phenotypes. Brain 1997; 120: 479-490.
15. Wallace RH, Wang DW, Singh R et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na(+)-channel beta-1 subunit gene SCN1B. Nature Genet 1998; 19: 366-370.
16. Baulac S, Gourfinkel-An I, Picard F et al. A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am J Hum Genet 1999; 65: 1078-1085.
17. Xiong L, Labuda M, Li D.-S, et al. Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12. Am J Hum Genet 1999; 65: 1698-1710.
18. Mikami M, Yasuda T, Terao A, et al. Localization of a gene for benign adult familial myoclonic epilepsy to chromosome 8q23.3-q24.1. Am J Hum Genet 1999; 65: 745-751.
19. Plaster NM, Uyama E, Uchino M et al. Genetic localization of the familial adult myoclonic epilepsy (FAME) gene to chromosome 8q24. Neurology 1999; 53:1180-1183.
20. Lehesjoki A-E, Koskiniemi M, Sistonen P et al. Localisation of a gene for progressive myoclonus epilepsy to chromosome 21q22. PNAS 1991; 88: 3696-3699.
21. Pennacchio LA, Lehesjoki A-E, Stone NE et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996; 271: 1731-1734.
22. Jarvela I, Schleutker J, Haataja L et al. Infantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1. Genomics 1991; 9: 170-173.
23. Vesa J, Hellsten E, Verkruyse LA et al. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 1995; 376: 584-587.
24. Sharp JD, Wheeler RB, Lake BD, Savukoski M, Jarvela IE, Peltonen L, Gardiner RM, Williams RE et al. Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 +15q21-23. Hum Mol Genet 1997; 6: 591-596.
25. Sleat, DE, Donnelly RJ, Lackland H et al. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 1997; 277: 1082-1086.
26. Eiberg H, Gardiner RM, Mohr J. Batten disease (Spielmeyer-Sjögren disease) and haptoglobins (HP): Indication of linkage and assignment to chromosome 16. Clin Genet 1989; 36: 217-218.
27. The International Batten Disease Consortium. Isolation of a novel gene underlying batten disease, CLN3. Cell 1995; 82: 949-957.
28. Savukoski M, Kestila M, Williams R et al. Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses. Am J Hum Genet 1994; 55: 695-701.
29. Savukoski M, Klockars T, Holmberg V, Santavuori P, Lander ES, Peltonen L. CLN5, a novel gene encoding a putative transmembrane protein mutated in finnish variant late infantile neuronal ceroid lipofuscinosis. Nature Genet 1998; 19: 286-288.
30. Tahvanainen E, Ranta S, Hirvasniemi A et al. The gene for a recessively inherited human childhood progressive epilepsy with mental retardation maps to the distal short arm of chromosome 8. PNAS 1994; 91: 7267-7270.
31. Ranta S, Zhang Y, Ross B, et al. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nature Genet 1999; 23: 233-236.
32. Serratosa JM, Delgado-Escueta AV, Posada I et al. The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. Hum Mol Genet 1995; 5: 1657-1663.
33. Minassian BA, Lee JR, Herbrick J.-A et al. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nature Genet 1998; 20: 171-174.
34. Serratosa JM, Gomez-Garre P, Gallardo ME et al. A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet 1999; 8: 345-352.
35. Greenberg DA, Delgado-Escueta AV, Widelitz H et al. Juvenile myoclonic epilepsy may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet 1988; 31: 185-192.
36. Weissbecker KA, Durner M, Janz D et al. Confirmation of linkage between juvenile myoclonic epilepsy locus and the HLA region on chromosome 6. Am J Med Genet 1991; 38: 32-36.
37. Durner M, Sander T, Greenberg DA et al. Localisation of idiopathic generalised epilepsy on chromosome 6p in families of juvenile myoclonic epilepsy patients. Neurology 1991; 41: 1651-1655.
38. Whitehouse WP, Rees M, Curtis D et al. Linkage analysis of idiopathic generalised epilepsy and marker loci on chromosome 6p in families of patients with juvenile myoclonic epilepsy: No evidence for an epilepsy locus in the HLA region. Am J Hum Genet 1993; 53: 652-662.
39. Liu AW, Delgado-Escueta AV, Serratosa JM et al. Juvenile myoclonic epilepsy locus in chromosome 6p21.2-p11:Linkage to convulsions and electroencephalography trait. Am J Hum Genet 1995; 57: 368-381.
40. Elmslie FV, Williamson MP, Rees M et al. Linkage analysis of juvenile myoclonic epilepsy and microsatellite loci spanning 61 cM of human chromosome 6p in 19 nuclear pedigrees provides no evidence for a susceptibility locus in this region. Am J Hum Genet 1996; 59: 653-663.
41. Elmslie FV, Rees M, Williamson MP et al. Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet 1997; 6: 1329-1334.
42. Zara F, Bianchi A, Avanzini G et al. Mapping of genes predisposing to idiopathic generalized epilepsy. Hum Mol Genet 1996; 4: 1201-1207.
43. Zara F, Labuda M, Garofalo PG et al. Unusual EEG pattern linked to chromosome 3p in a family with idiopathic generalized epilepsy. Neurology 1998; 51: 493-498.
44. Fong GCY, Shah PU, Gee MN, et al. Childhood absence epilepsy with tonic-clonic seizures and electroencephalogram 3-4-Hz spike and multispike-slow wave complexes: Linkage to chromosome 8q24. Am J Hum Genet 1998; 63: 1117-1129.
45. Wallace RH, Berkovic SF, Howell RA et al. Suggestion of a major gene for familial febrile convulsions mapping to 8q13-21. J Med Genet 1996; 33: 308-312.
46. Johnson EW, Dubovsky J, Rich SS et al. Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest. Hum Mol Genet 1998; 7: 63-67.
47. Peiffer A, Thompson J, Charlier C et al. A locus for febrile seizures (FEB3) maps to chromosome 2q23-24. Ann Neurol 1999; 46: 671-678.
48. Nakayama J, Hamano K, Iwasaki N et al. Significant evidence for linkage of febrile seizures to chromosome 5q14-q15. Hum Mol Genet 2000; 9: 87-91.
49. Ryan SG, Chance PF, Zou C-H et al. Epilepsy and mental retardation limited to females: An X-linked dominant disorder with male sparing. Nature Genet 1997; 17: 92-95.
50. Fryer AE, Chalmers A, Connor JM et al. Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1987; i: 659-661.
51. van Slegtenhorst M, de Hoogt R, Hermans C et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997; 277: 805-808.
52. Kandt RS, Haines JL, Smith M et al. Linkage of an important gene locus to a chromosome 16 marker for polycystic kidney disease. Nature Genetics 1992; 2: 37-41.
53. European chromosome 16 tuberous sclerosis consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993; 75: 1305-1315.
54. Chan CT, Clayton-Smith J, Cheng XJ et al. Molecular mechanisms in Angelman syndrome: A survey of 93 patients. J Med Genet 1993; 30: 895-902.
55. Kishino T, Lalande M, Wagstaff J et al. UBE3A/E6-AP mutations cause Angelman syndrome. Nature Genet 1997; 15: 70-73.
56. Matsuura T, Sutcliffe JS, Fang P et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nature Genet 1997; 15: 74-77.
57. Barker D, Wright E, Nguyen K et al. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 1987; 236: 1100-1102.
58. Xu GF, O Connell P, Viskochil D et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990; 62: 599-608.
59. Verkerk AJMH, Pieretti M, Sutcliffe JS et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991; 65: 905-914.
60. Filippi G, Rinaldi A, Archidiacono N et al. Linkage between G6PD and fragile-X syndrome. Am J Med Genet 1983; 15: 113-119.